LIGAND PHARMACEUTICALS INC - 53220K207

Sector: No information yet · Industry: No information yet
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q1 2014 · Q4 2013
Value (USD)
Total reported value ($000)
$1.399M
QoQ value delta ($000)
-$3.777M (-72.97%)
Implied price effect (QoQ)
+27.87%
Shares
Total shares
20,800
QoQ shares delta
-77,600 (-78.86%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Top holders (Q1 2014)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
Benchmark Capital Advisors 1,399 20,800 0.97%